<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">Manu S. Sharma</th>
</tr>
<tr> [@sharma2019]
<td class="infobox-image" colspan="2">
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>University of California San Diego<br>Alzheimer's Disease Cooperative Study</td>
</tr>
<tr>
<td class="label">Country</td>
<td>USA</td>
</tr>
<tr>
<td class="label">H-index</td>
<td>200</td>
</tr>
<tr>
<td class="label">ORCID</td>
<td><a href="https://orcid.org/0000-0002-0184-4183" target="_blank">0000-0002-0184-4183</a></td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>Clinical Trials, Amyloid, Tau, Alzheimer's Disease</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Immunotherapy, Anti-amyloid antibodies, Anti-tau therapeutics, Clinical endpoints</td>
</tr>
</table>
Manu S. Sharma plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">Manu S. Sharma</th>
</tr>
<tr> [@sharma2019]
<td class="infobox-image" colspan="2">
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>University of California San Diego<br>Alzheimer's Disease Cooperative Study</td>
</tr>
<tr>
<td class="label">Country</td>
<td>USA</td>
</tr>
<tr>
<td class="label">H-index</td>
<td>200</td>
</tr>
<tr>
<td class="label">ORCID</td>
<td><a href="https://orcid.org/0000-0002-0184-4183" target="_blank">0000-0002-0184-4183</a></td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>Clinical Trials, Amyloid, Tau, Alzheimer's Disease</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Immunotherapy, Anti-amyloid antibodies, Anti-tau therapeutics, Clinical endpoints</td>
</tr>
</table>
Manu S. Sharma plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Manu S. Sharma is a distinguished Alzheimer's disease clinical researcher at the University of California, San Diego (UCSD) School of Medicine. With an h-index of 200, Dr. Sharma is one of the most influential clinical trialists in the Alzheimer's disease field, having led numerous Phase I-III clinical trials for novel Alzheimer's therapeutics. His work has been particularly focused on immunotherapies targeting [amyloid-beta](/proteins/amyloid-beta) and [tau protein](/proteins/tau), two hallmark pathologies of Alzheimer's disease.
Dr. Sharma serves as the Associate Director of the Alzheimer's Disease Cooperative Study (ADCS), a major NIH-funded clinical trials consortium dedicated to developing new treatments for Alzheimer's disease and related disorders.
Dr. Sharma has been instrumental in designing, leading, and interpreting numerous landmark Alzheimer's disease clinical trials. His expertise spans the full spectrum of clinical development from early-phase safety studies to large-scale Phase III registration trials.
Dr. Sharma has played a leading role in the evaluation of monoclonal antibodies targeting [amyloid-beta](/proteins/amyloid-beta) plaques:
Recognizing that amyloid-targeting alone may not be sufficient, Dr. Sharma has also pioneered anti-tau therapeutic approaches:
Dr. Sharma has made significant contributions to improving clinical trial methodology for Alzheimer's disease:
Dr. Sharma has authored over 300 peer-reviewed publications in leading journals. Some of his most influential works include:
Dr. Sharma's clinical research has contributed to understanding:
Dr. Sharma maintains active collaborations with leading researchers worldwide:
As a senior investigator at UCSD, Dr. Sharma has trained numerous clinical researchers who have gone on to lead their own clinical trials programs. He has mentored over 30 postdoctoral clinical fellows and junior faculty members.
Dr. Sharma has received numerous awards for his contributions to Alzheimer's disease research, including recognition from the Alzheimer's Association and the American Academy of Neurology.
Manu S. Sharma plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Manu S. Sharma has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.